HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

PRCT

PROCEPT BioRobotics Corporation (NASDAQ)

Healthcare — Medical Devices

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Buy 2.1 / 5 10 analysts
$17.91
$-0.61 (-3.32%)
Target: $30.20 (68.6%)
Sign in to add PRCT to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$1.34B
P/E Ratio (TTM)-
Forward P/E-26.98
EPS (TTM)$-1.83
Dividend Yield-
Profit Margin-31.82%
Revenue Growth20.20%
ROE-27.82%
Debt/Equity22.43
Recommendation Buy 2.1
Analyst Target$30.20
Analysts10
Indexes NASDAQ

Technical Indicators

RSI (14)28.4
Beta0.85
SMA 20-
SMA 40-
52-Week High$62.17
52-Week Low$19.35
50-Day Avg$25.18
200-Day Avg$29.34
Avg Volume$1.63M
Volume563.9K

Performance Analysis

BULLISH

PRCT shows predominantly bullish signals based on its fundamentals and technicals.

+ Trading near its 52-week low ($19.35), which could present a value opportunity.
+ RSI at 28.4 signals oversold conditions — a bounce may be ahead.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ Strong revenue growth of 20.2% year-over-year.
- Operating at a loss with -31.8% margin.
+ Wall Street consensus is "Buy" from 10 analysts.
+ Average analyst target of $30.20 implies 68.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:27 UTC

Back to Screener Export Report